CYTOKINETICS, INCORPORATED Other Preferred Stock Dividends and Adjustments
CYTOKINETICS, INCORPORATED (CYTK) reported Other Preferred Stock Dividends and Adjustments of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherPreferredStockDividendsAndAdjustments · last filed 2015-03-06
- CYTOKINETICS, INCORPORATED other preferred stock dividends and adjustments for the quarter ending 2012-12-31 was $0.00.
- CYTOKINETICS, INCORPORATED other preferred stock dividends and adjustments for the quarter ending 2012-09-30 was $0.00.
- CYTOKINETICS, INCORPORATED other preferred stock dividends and adjustments for the quarter ending 2012-06-30 was $1.31M, a 54.25% decline year-over-year.
- CYTOKINETICS, INCORPORATED other preferred stock dividends and adjustments for the quarter ending 2011-12-31 was $0.00.
- CYTOKINETICS, INCORPORATED other preferred stock dividends and adjustments for fiscal 2014 was $0.00.
- CYTOKINETICS, INCORPORATED other preferred stock dividends and adjustments for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- CYTOKINETICS, INCORPORATED other preferred stock dividends and adjustments for fiscal 2012 was $1.31M, a 54.25% decline from fiscal 2011.
- CYTOKINETICS, INCORPORATED other preferred stock dividends and adjustments for fiscal 2011 was $2.86M.
| Period end | Other Preferred Stock Dividends and Adjustments 3 month | Other Preferred Stock Dividends and Adjustments 6 month | Other Preferred Stock Dividends and Adjustments 9 month | Other Preferred Stock Dividends and Adjustments 12 month | Other Preferred Stock Dividends and Adjustments 167 month | Other Preferred Stock Dividends and Adjustments 170 month | Other Preferred Stock Dividends and Adjustments 173 month | Other Preferred Stock Dividends and Adjustments 176 month | Other Preferred Stock Dividends and Adjustments 179 month | Other Preferred Stock Dividends and Adjustments 182 month | Other Preferred Stock Dividends and Adjustments 185 month | Other Preferred Stock Dividends and Adjustments 188 month | Other Preferred Stock Dividends and Adjustments 191 month | Other Preferred Stock Dividends and Adjustments 194 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-03-06 | |||||||||||||
| 2013-12-31 | $0.00 10-K · filed 2015-03-06 | |||||||||||||
| 2013-09-30 | $4.16M 10-Q · filed 2013-11-06 | |||||||||||||
| 2013-06-30 | $4.16M 10-Q · filed 2013-08-07 | |||||||||||||
| 2013-03-31 | $4.16M 10-Q · filed 2013-05-08 | |||||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-06 | $0.00 derived: sum of 2 quarters · filed 2015-03-06 | $1.31M derived: sum of 3 quarters · filed 2015-03-06 | $1.31M 10-K · filed 2015-03-06 | $4.16M 10-K · filed 2013-03-15 | |||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $1.31M derived: sum of 2 quarters · filed 2013-11-06 | $1.31M 10-Q · filed 2013-11-06 | $4.16M 10-Q · filed 2012-11-07 | ||||||||||
| 2012-06-30 | $1.31M 10-Q · filed 2013-08-07 | $1.31M 10-Q · filed 2013-08-07 | $4.16M 10-Q · filed 2012-08-06 | |||||||||||
| 2012-03-31 | $2.86M 10-Q · filed 2012-05-04 | |||||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $0.00 derived: sum of 2 quarters · filed 2014-03-07 | $2.86M derived: sum of 3 quarters · filed 2014-03-07 | $2.86M 10-K · filed 2014-03-07 | $2.86M 10-K · filed 2012-03-13 | |||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $2.86M derived: sum of 2 quarters · filed 2012-11-07 | $2.86M 10-Q · filed 2012-11-07 | $2.86M 10-Q · filed 2011-11-04 | ||||||||||
| 2011-06-30 | $2.86M 10-Q · filed 2012-08-06 | $2.86M 10-Q · filed 2012-08-06 | $2.86M 10-Q · filed 2011-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |